FONAR Supplements Go-Private Merger Proxy Amid Shareholder Litigation
FONR sits 42% above its 52-week low of $13.33 on elevated volume (3.4× avg).
Summary
FONAR filed supplemental proxy materials addressing shareholder litigation related to its $19.00 per share go-private merger, providing key clarifications on the deal's background and valuation.
Key Events · M&A and Partnerships · FONR
-
Merger Litigation Response
FONAR issued supplemental disclosures to its definitive proxy statement in response to shareholder demand letters and draft complaints alleging deficiencies in merger disclosures.
-
No "Don't Ask-Don't Waive" Provisions
The company clarified that non-disclosure agreements did not contain "don't ask-don't waive" standstill provisions, allowing alternative bidders to submit topping bids.
-
Financial Projection Amendments
Supplemental disclosures include amendments to the financial projections used by Marshall & Stevens in their fairness opinion, specifically adding a terminal value component.
-
Share Count for Valuation Clarified
The filing details the fully diluted share count (6,644,553 common-equivalent shares) used in the valuation analysis for the $14.63 per share liquidation scenario.
Analysis · FONR · Industrial Applications And Services
FONAR has issued supplemental disclosures to its definitive proxy statement for the proposed $19.00 per share go-private merger. These updates, made in response to shareholder litigation, clarify the merger's background, confirm the absence of "don't ask-don't waive" provisions in non-disclosure agreements, and amend financial projections used in the fairness opinion. These details are crucial for shareholders to assess the fairness of the offer and the integrity of the merger process ahead of the May 28th vote, especially as the stock trades near its 52-week high, closely tracking the offer price.
At the time of this filing, FONR was trading at $18.94 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $118.9M. The 52-week trading range was $13.33 to $18.95. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.